PI
BMY icon

Panthera Investment’s Bristol-Myers Squibb BMY Stock Holding History

Panthera Investment’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$52K Buy
800
+400
+100% +$25K 0.01% 123
2014
Q4 		$24K Sell
400
-2,000
-83% -$113K 0.01% 83
2014
Q3 		$123K Sell
2,400
-14,800
-86% -$739K 0.04% 63
2014
Q2 		$834K Buy
+17,200
New +$848K 0.39% 33

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Panthera Investment's BMY Position: Q1 2015 in Review

Panthera Investment reduced its Bristol-Myers Squibb (BMY) stake by 62% in Q1 2015, selling an estimated $44.1K and leaving 438 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #132.

Panthera Investment first reported a position in BMY in Q2 2014 and has held it in 4 quarters since. The position peaked at $565K in Q2 2014. 1,450 funds tracked by Wall St. Rank hold BMY as of Q1 2015.

  • Panthera Investment held 438 shares of Bristol-Myers Squibb worth $28K as of Q1 2015.
  • Panthera Investment sold 704 Bristol-Myers Squibb shares in Q1 2015, an estimated $44.1K.
  • Bristol-Myers Squibb made up 0.01% of Panthera Investment's portfolio in Q1 2015, its #132 holding.
  • Panthera Investment first reported a position in Bristol-Myers Squibb in Q2 2014 and has held it in 4 quarters since.
  • Panthera Investment's Bristol-Myers Squibb position peaked at $565K in Q2 2014.
  • 1,450 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2015.

Based on Panthera Investment's 13F filing for Q1 2015, filed 15 May 2015.